Taking place from 28-30 October 2026 at Mandalay Bay, Las Vegas, USA, SupplySide Global 2026 brings together global professionals from across the health, nutrition, food and wellness industries.
At Booth 6177, PhytoGaia will highlight how its research-driven approach is translating scientific discoveries into new opportunities across healthy ageing, nutrition, beauty wellness, while making its first SupplySide Global showcase of pet wellness solutions. The company will also open conversations with brand owners and industry partners interested in collaborative research and product development via its inaugural Annual Research Grant Program.
Whats’s New at Booth 6177?
STGaia - A new approach to healthy ageing and beauty
An award-winning novel plant squalene + tocotrienol complex, STGaia, brings an ‘Outside-In and Inside-Out’ approach in addressing both visible and non-visible signs of ageing to support healthy ageing, longevity and beauty-from-within. STGaia® was recently recognised as the NutraIngredients Asia Awards 2025 – Ingredient of the Year: Healthy Ageing, reflecting growing interest in innovative approaches to healthy ageing, longevity and beauty-from-within.
At Supplyside Global, PhytoGaia will showcase how STGaia can move from a differentiated ingredient to practical product opportunities for brands looking to explore the growing healthy ageing, longevity and beauty-from-within markets.
TocoGaia – New clinical research insights
PhytoGaia will also share the latest research findings from its clinical research portfolio on TocoGaia, its natural full spectrum tocotrienols/tocopherol complex. The findings demonstrated the potential role of TocoGaia in supporting liver health, with studies related to metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated fatty liver disease (AFLD). These findings add to PhytoGaia’s growing body of scientific research and its continued interest in exploring new health applications for tocotrienols, particularly in relation to metabolic health.
PetGaia – Bringing palm phytonutrients to pet wellness
For the first time at SupplySide Global, PhytoGaia will present findings from an 8-week randomised, placebo-controlled canine clinical study investigating multiple clinically assessed skin and coat parameters. The clinical research supports the potential of PetGaia in skin and coat health in companion animals, with findings across areas including skin hydration, pruritus, skin redness, lesions and shedding in dogs.
PetGaia was also recently recognised as Pet Ingredient Innovation of the Year 2026, highlighting its potential for next-generation pet wellness products. New product concepts featuring PetGaia™ include chewable tablets, softgels and dropper formats, including the PawGaia dropper, demonstrating how the ingredient can be incorporated into different pet wellness applications.
At SupplySide Global, PhytoGaia will also invite pet wellness professionals, industry partners and pet owners to participate in an 8-week PawGaia Challenge. Participants can stop by Booth 6177 to learn more about the programme and receive a PawGaia dropper sample to take part.
From ingredients to product concepts
Beyond individual ingredients, PhytoGaia will introduce a range of new product developments concepts designed to demonstrate how its branded ingredients can be translated into market-ready applications.
Featured concepts include:
- Healthy Ageing: Vegetarian softgels, liquid capsules, functional jellies and other innovative delivery formats featuring STGaia, including a sports bar.
- Beauty Wellness: ‘Outside-In and Inside-Out’ concepts supporting skin, hair and healthy ageing.
- Pet Wellness: Chewable tablets, softgels and dropper formats featuring PetGaia including the PawGaia dropper.
SupplySide Global is always an exciting opportunity for us to reconnect with valued partners and meet new industry innovator. This year, we look forward to sharing the latest findings from our research, including studies exploring metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated fatty liver disease (AFLD), as well as findings from our canine clinical study investigating skin and coat health. We are excited to exchange ideas, discuss new opportunities and explore how these research insights can contribute to the development of innovative health and wellness solution.
Said Dr. Ariati Aris, Scientific Affairs Specialist at PhytoGaia.
Research, collaboration and new opportunities
Looking beyond the exhibition floor, PhytoGaia is preparing to launch its Annual Research Grant Programme, further strengthening its commitment to scientific research and collaboration. The upcoming programme will support collaborative research with universities and research institutions to further explore the potential and applications of PhytoGaia's branded ingredients, while generating new scientific evidence and translating research findings into science-backed ingredients, formulation and product solutions.
PhytoGaia is also open to collaborative research opportunities with brand owners and industry partners interested in exploring specific product applications, formulation concepts and consumer needs.
The future of health and wellness lies in bringing together strong science, innovative ingredients and the right industry partnerships.
Commented Mr. Bryan See, Vice President of PhytoGaia.
At Supplyside Global 2026, we want to go beyond showcasing our ingredients and demonstrate the possibilities they can offer to the market. We look forward to engaging with brand owners, formulators and industry leaders to explore new product development opportunities, research collaborations and health and wellness concepts across healthy ageing, beauty, nutrition, and pet wellnes.
Added Mr. See.
Discover what’s next in health and wellness with PhytoGaia. Meet the team at Booth 6177 and explore new opportunities for innovation, research and product development. To schedule a meeting with the PhytoGaia team at SupplySide Global 2026, contact info@phytogaia.com.
Disclaimer: The statements in the above article have not been evaluated by the Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.
